机构差异对乳腺癌大分割全乳放疗种族差异的影响
该研究基于密歇根州25家机构的前瞻性质量联盟数据库,分析2012至2018年9634例保乳术后接受全乳放疗的乳腺癌患者,发现黑人和亚裔患者接受大分割放疗的比例低于白人,多水平模型校正后种族差异消失,提示机构层面的大分割使用差异是造成差异的原因。
要点
- 多水平模型校正机构聚类后种族差异不再显著,提示机构因素是差异来源。
核心结论
- 黑人和亚裔患者接受大分割全乳放疗的比例低于白人,但该差异可被机构层面因素解释。
研究设计与样本
- 前瞻性收集的密歇根州25家机构质量联盟数据库,纳入2012年1月至2018年12月保乳术后完成大分割或常规分割全乳放疗的乳腺癌患者9634例。
主要发现
- 9634例患者中81%自报白人、17%黑人、2%亚裔;31.7%白人患者在教学中心治疗,黑人和亚裔分别为66.7%和64.8%。
- 多水平分析校正机构内患者聚类后,种族与大分割使用不再显著相关。
临床怎么用
- 关注本机构大分割全乳放疗的使用模式,识别并减少机构层面变异可能有助于缩小种族差异。
局限性
- 原文未报告多水平分析的具体效应量及置信区间。
- 原文未报告导致机构间大分割使用差异的具体机构特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hypofractionated radiation therapy is a less burdensome and less costly approach that is efficacious for most patients with early-stage breast cancer. Concerns about racial disparities in adoption of medical advances motivate investigation of the use of hypofractionated radiation in diverse populations. The goal of our study was to determine whether hypofractionated whole breast radiation therapy after breast-conserving surgery was being similarly used across racial groups in the state of Michigan. METHODS AND MATERIALS: A prospectively collected statewide quality consortium database from 25 institutions was queried for patients with breast cancer who completed hypofractionated (HF) or conventionally fractionated whole breast radiation therapy from January 2012 to December 2018. We used patient-level multivariable modeling to evaluate associations between HF use and race, controlling for patient and facility factors, and multilevel modeling to account for patient clustering within facilities. RESULTS: Of 9634 patients analyzed, 81% self-reported race as white, 17% as black, and 2% as Asian, similar to statewide and national distributions. In addition, 31.7% of whites were treated at teaching centers compared with 66.7% of blacks and 64.8% of Asians. In 2018, HF was used in 72.7% of whites versus 56.7% of blacks and 67.6% of Asians (P = .0411). On patient-level multivariable analysis, black and Asian races were significantly associated with a lower likelihood of HF receipt (P < .001), despite accounting for treatment year, age, laterality, body mass index, breast volume, comorbidities, stage, triple-negative status, intensity modulated radiation therapy use, teaching center treatment, and 2011 American Society for Radiation Oncology Hypofractionation Guideline eligibility. On multilevel analysis, race was no longer significantly associated with HF receipt. CONCLUSIONS: We observed that black and Asian patients receive hypofractionated whole breast radiation therapy less often than whites, despite more frequent treatment at teaching centers. Multilevel modeling eliminated this disparity, suggesting that differences in facility-specific HF use appear to have contributed. Further inquiry is needed to determine whether reduction of facility-level variation may reduce disparities in accessing HF treatment.
引用
- Laucis AM, Jagsi R, Griffith KA, et al. The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020. PMID: 32376311. doi:10.1016/j.ijrobp.2020.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。